Background illustration for clinical trials search

Paid Clinical Trials Aurora

Discover 1,584 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

for
Primary Immunoglobulin A Nephropathy (IgAN)
Location: Aurora CO, Salt Lake City UT, Madera CA, Gainesville FL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 18

Code: NCT06994845

Phase3, Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Aurora CO, Minneapolis MN, Memphis TN, Palo Alto CA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase1, Phase2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Aurora CO, Salt Lake City UT, Kansas City MO,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase1, Phase2, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Aurora CO, Salt Lake City UT, Lehi UT, Lincoln NE,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

for
Neuroblastoma
Location: Aurora CO, Fort Worth TX, Dallas TX, Los Angeles CA,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All

Age: 1 - 31

Code: NCT06450041

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Aurora CO, Dallas TX, Iowa City IA, Austin TX,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase3, Recruiting

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

for
Premature Infant, Chronic Respiratory Disease,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 40

Code: NCT03797183

Recruiting

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Aurora CO, Dallas TX, Austin TX, Saint Louis MI,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

Safety of Short-course of NSAIDs in Pediatric Patients With CKD

for
Chronic Kidney Disease, Pediatric Urology
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 1 - 25

Code: NCT06860711

Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for
Heart Transplant, Pediatric Heart Transplant, Rejection,
Location: Denver CO, Little Rock AR, St Louis MO, San Diego CA,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for
Ig-E Mediated Food Allergy
Location: Aurora CO, Denver CO, Colorado Springs CO, Phoenix AZ,
Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Aurora CO, Denver CO, Salt Lake City UT, Wichita KS,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

for
Fragile X Syndrome
Location: Aurora CO, Phoenix AZ, Minneapolis MN, Irvine CA,
Sponsor: Mirum Pharmaceuticals, Inc.

Sex: Male

Age: 13 - 45

Code: NCT07209462

Phase2, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Aurora CO, Denver CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Denver CO, Dallas TX, Iowa City IA, Austin TX,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

for
Recessive Dystrophic Epidermolysis Bullosa
Location: Aurora CO, Chicago IL, Galveston TX, Palo Alto CA
Sponsor: Abeona Therapeutics, Inc

Sex: All

Age: 0+

Code: NCT07700966

Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Aurora CO, Salt Lake City UT, Sioux Falls SD, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase1, Phase2, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Aurora CO, West Jordan UT, Layton UT, Provo UT,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase3, Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: Aurora CO, Fort Worth TX, Houston TX, Indianapolis IN,
Sponsor: Allterum Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07586618

Phase1, Recruiting

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

for
Down Syndrome
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 6 - 22

Code: NCT07598643

Phase2, Recruiting